Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × tucatinib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 17 HER2-positive Breast Cancer 5 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Neoplasms 3 Meningeal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Brain Neoplasms 2 Rectal Neoplasms 1 Pathologic Complete Response 1 Metastatic Breast Cancer With a Isolated Brain Progression 1 Meningeal Carcinomatosis 1 Hemangiosarcoma 1 HER2-positive Metastatic Breast Cancer 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Cisplatin 5 pembrolizumab 4 durvalumab 4 Pemetrexed 4 palbociclib 3 Nivolumab 3 Fulvestrant 3 Carboplatin 3 Anastrozole 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 pralsetinib 2 cobimetinib 2 atezolizumab 2 abemaciclib 2 Vemurafenib 2 Radiosurgery 2 Paclitaxel 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 Bevacizumab 2 Ascorbic Acid 2 AZD9833 2 trametinib 1 taletrectinib 1 spartalizumab 1 sotorasib 1 repotrectinib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡